igk and Triple-Negative-Breast-Neoplasms

igk has been researched along with Triple-Negative-Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for igk and Triple-Negative-Breast-Neoplasms

ArticleYear
Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer.
    International journal of molecular sciences, 2023, Oct-16, Volume: 24, Issue:20

    Due to a higher mutational load, triple-negative breast cancer (TNBC) is characterized by a higher immunogenicity compared to other subtypes. In this context, we analyzed the prognostic significance of tumor-infiltrating plasma cells in a cohort of 107 triple-negative breast cancer patients. Tumor-infiltrating plasma cells were analyzed via immunohistochemistry using the plasma cell markers CD38 and IgκC. The prognostic impact of the CD38 and IgκC expression was evaluated using the Kaplan-Meier plots and Cox regression analyses. A Spearman-Rho correlation coefficient was used to evaluate a possible association between plasma cell infiltration and the

    Topics: Biomarkers, Tumor; Disease-Free Survival; Humans; Lymphocytes, Tumor-Infiltrating; Plasma Cells; Prognosis; Triple Negative Breast Neoplasms

2023